By Bilal Hafeez 12-11-2020
In: hive-podcasts | COVID-19

Ep. 37: Professor Justin Stebbing On Vaccine Breakthroughs And Herd-Immunity By Summer

(1 min read)
Resize text:


 

This episode is supported by private equity platform Moonfare.

In this show, I talk with Professor Justin Stebbing. I had him as a guest in July when he argued that we could see a COVID vaccine around US election time. He was right and so I wanted to get his latest views. For background, Justin is a professor in the Faculty of Medicine at Imperial college London. He specializes in cancers and immunotherapies. He has an extensive research background having published over 550 peer-reviewed papers. Earlier this year, he published in the Lancet new research on using AI to find drugs to treat COVID-19 and recently published in Foreign Affairs China’s global role in vaccine distribution. In this podcast we discuss:

  1. The significance of Pfizer’s 90% efficacy rate
  2. Vaccines from other pharma companies including from Russia & China
  3. The science of vaccines – B-cell and T-cell responses
  4. Fast tracking of vaccine approval by FDA
  5. Managing public opinion and anti-vaxxers
  6. Logistics of vaccine distribution
  7. When will we get to herd-immunity
  8. Remaining uncertainties around vaccines
  9. Mink factories and mutations
  10. Long COVID and athletes
  11. Which countries have secured vaccine supplies

You can contact Justin on his Imperial page.

Make sure to subscribe to the show on AppleSpotify, YouTube, or wherever you go for your podcasts. You can follow us on Twitter and LinkedIn.

 

 

(The commentary contained in the above article does not constitute an offer or a solicitation, or a recommendation to implement or liquidate an investment or to carry out any other transaction. It should not be used as a basis for any investment decision or other decision. Any investment decision should be based on appropriate professional advice specific to your needs.)

 

 


For access to our Slack Chat Room, where we discuss all things markets with our researchers and subscribers

START YOUR FREE TRIAL


MOST READ

Successful Start-Ups Build Strong Founding Teams (4 min read)

By Sam van de Schootbrugge | Feb 10, 2021
Start-up success hinges on many factors, but most would agree that the skills and experience of the founder and initial founding...

Where Will the Economy Find 10 million Lost Jobs? (3 min read)

By John Tierney | Feb 08, 2021
The headline January labour market report was another downer – private payrolls rose a scant 6,000 versus the consensus...

Where Can you Get Higher Bond Yields?

By Caroline Grady | Dec 04, 2020
US yields are rising. The combination of growing optimism over a global recovery given vaccine progress, and the possibility of a US...

PREMIUM CONTENT

The Fed is Failing (1 min read)

By Bilal Hafeez | Mar 01, 2021
The Fed’s failure is neither that rates…

Do ESG Ratings Affect IPO Valuations? (4 min read)

By Sam van de Schootbrugge | Mar 03, 2021
Summary A new Journal of Corporate Finance…

Want To Join Our Community Of Leading Investors And Researchers In Our Slack Chat Room?